Clean and conservative Below 12 mg/mL, the 12 mg dose volume exceeds 1 mL, requiring either a tuberculin syringe or splitting the injection
The table below sums up the key differences seen in research
The primary unresolved safety concern is the VEGF/angiogenesis-cancer risk no study has directly tested BPC-157 in established tumour models, and the theoretical risk of VEGF upregulation supporting tumour vascularisation in a cancer context is legitimate and uncharacterised
Mechanism in research literature NNMT (nicotinamide N-methyltransferase) catalyses the methylation of nicotinamide using S-adenosylmethionine (SAM) as the methyl donor, producing 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine
-glutamyl kinase (GK) encoded by PRO1 in eukaryotes or proB in prokaryotes, the first enzyme in proline biosynthetic pathway, catalyzes the formation of intermediate -glutamyl phosphate, which if accumulated could partially react with cysteine to generate -GC, and then Gsh2 adds glycine to -GC to form GSH
These symptoms correlate with poorer semen parameters